(Q46958764)

English

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.

scientific article published on 22 February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16495935%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16495935%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

based on heuristic

inferred from title

Kenji Hashimoto

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16495935%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Yuko Fujita

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16495935%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Masaomi Iyo

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16495935%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

0 references

publication date

22 February 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16495935%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Neuropsychopharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16495935%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

32

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16495935%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16495935%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

514-521

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16495935%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301047

0 references

The role of sigma receptors in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

The glutamatergic dysfunction hypothesis for schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Rolipram, a selective phosphodiesterase type-IV inhibitor, prevents induction of heat shock protein HSP-70 and hsp-70 mRNA in rat retrosplenial cortex by the NMDA receptor antagonist dizocilpine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Regulating ankyrin dynamics: Roles of sigma-1 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Glutamate as a therapeutic target in psychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Reversal of Phencyclidine-Induced Dopaminergic Dysregulation by N-Methyl-D-Aspartate Receptor/Glycine-site Agonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Neurocognitive impairment across the lifespan in schizophrenia: an update

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Repeated administration of phencyclidine, amphetamine and MK-801 selectively impairs spatial learning in mice: a possible model of psychotomimetic drug-induced cognitive deficits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

SA4503, a novel cognitive enhancer, with sigma 1 receptor agonistic properties.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

The interaction between neuroactive steroids and the σ1 receptor function: behavioral consequences and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Bringing order to the glutamate chaos in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Neuropharmacological profile of a novel potential atypical antipsychotic drug Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)- 6H-[1]benzothieno[2,3-b][1,5] benzodiazepine maleate).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Adenosine A1 Receptor Agonists Block the Neuropathological Changes in Rat Retrosplenial Cortex after Administration of the NMDA Receptor Antagonist Dizocilpine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Selective serotonin reuptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

A perspective on the new mechanism of antidepressants: neuritogenesis through sigma-1 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Genetic enhancement of learning and memory in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Differential effects of enrichment on learning and memory function in NR2B transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

The antidepressant-like effect induced by the sigma(1) (sigma(1)) receptor agonist igmesine involves modulation of intracellular calcium mobilization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

Effects of sigma(1) receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvoxamine as an adjunctive agent in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301047

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46958764&oldid=2099771241"